Daniele Santini | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions	ONCOGENE	2021
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index	JOURNAL OF GASTROINTESTINAL CANCER	2021
Osteoblasts Promote Prostate Cancer Cell Proliferation Through Androgen Receptor Independent Mechanisms	FRONTIERS IN ONCOLOGY	2021
Response to: Successful afatinib rechallenge in a patient with non-small cell lung cancer harboring EGFR G719C and S768I mutations	THORACIC CANCER	2021
Effects of abiraterone acetate plus prednisone on bone turnover markers in chemotherapy-naïve mCRPC patients after ADT failure: A prospective analysis of the italian real-world study ABITUDE	JOURNAL OF BONE ONCOLOGY	2021
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index	JOURNAL OF GASTROINTESTINAL CANCER	2021
Multiple and Concomitant Molecular Findings in a Heavily Treated Patient With EGFR-positive Lung Cancer	CLINICAL LUNG CANCER	2021
Second-line eribulin in triple negative metastatic breast cancer patients. Multicentre retrospective study: The tetris trial	INTERNATIONAL JOURNAL OF MEDICAL SCIENCES	2021
Impact of Previous Nephrectomy on Clinical Outcome of Metastatic Renal Carcinoma Treated With Immune-Oncology: A Real-World Study on Behalf of Meet-URO Group (MeetUro-7b)	FRONTIERS IN ONCOLOGY	2021
Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines	ANNALS OF ONCOLOGY	2021
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma	BIOLOGY	2021
S-Adenosylmethionine Supplementation May Reduce Cancer-Related Fatigue: A Prospective Evaluation Using the FACIT-F Questionnaire in Colon Cancer Patients Undergoing Oxaliplatin-Based Chemotherapy Regimens	CHEMOTHERAPY	2021
Deep Learning Algorithm Trained with COVID-19 Pneumonia Also Identifies Immune Checkpoint Inhibitor Therapy-Related Pneumonitis	CANCERS	2021
Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study)	CLINICAL MEDICINE INSIGHTS: ONCOLOGY	2021
Bone metastases from urothelial carcinoma. The dark side of the moon	JOURNAL OF BONE ONCOLOGY	2021
Metastatic Renal Cell Carcinoma Classified as Good Risk: The Easiest Choice Has Become the Hardest	CHEMOTHERAPY	2021
CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies	BRITISH JOURNAL OF CANCER	2021
966P Diabetes therapy burden as proxy of impairment of immune checkpoint inhibitors efficacy	ANNALS OF ONCOLOGY	2021
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients. Results of the VICTOR-6 study	BREAST CANCER RESEARCH AND TREATMENT	2021
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence	JOURNAL OF CELLULAR PHYSIOLOGY	2020